Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Saw palmetto extract can block the enzyme that converts testosterone in pig prostate cells.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Baricitinib is the most effective treatment for alopecia areata.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

CARASIL, a rare genetic disorder, was confirmed in an Arabic woman, highlighting its rarity and need for stroke prevention.

Finasteride helps reduce priapism in sickle cell anemia patients.

Women also use 5α-reductase inhibitors, and their effects differ from men.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Baricitinib helps treat severe hair loss in people over 65.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Tofacitinib may work better than methotrexate for treating moderate-to-severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Finasteride does not negatively affect male reproductive function.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Apremilast showed mixed results for treating severe alopecia areata.

Finasteride and dutasteride reduce semen quality, with dutasteride having a stronger negative effect.